Clinical Trial

EEG Prediction and Clinical Efficacy of tDCS in Major Depression

Study acronym: DM-TDCS-PREDIC
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this randomized controlled trial is to investigate the non-inferiority, and possible superiority, of a high-dose home-based tDCS protocol compared with a conventional home-based protocol, and to assess its cost-effectiveness, in patients with major depression. As a secondary aim, we aim to assess the predictive value of baseline EEG for clinical response to high-dose home-based tDCS treatment in patients with major depression.
Protocol Amendment History 1 change
critical Recruitment opened 2026-07-08
Trial Details
NCT Number NCT07611773
Lead Sponsor Ionclinics & Deionic SL
Collaborators: Hospital Universitario Doctor Peset, Universidad Europea de Valencia
Conditions Depression - Major Depressive Disorder
Enrollment 270 participants
Start Date 2026-06-14
Primary Completion 2028-06-30 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-07